Market research
MEM.AU Memphasys Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 15M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.46
Community
Investor discussion
1 comment
Sign in to join the MEM.AU discussion.
5 years, 5 months ago
Memphasys Limited is currently in a long term downtrend where the price is trading 26.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Its net income has increased by 3.7% to $-719K since the same quarter in the previous year.
Finally, its free cash flow grew by 124.3% to $363K since the same quarter in the previous year.
Based on the above factors, Memphasys Limited gets an overall score of 3/5.